Elastic, Degradable Vascular Grafts with Helical Microfibers
具有螺旋微纤维的弹性、可降解血管移植物
基本信息
- 批准号:10685260
- 负责人:
- 金额:$ 62.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgingAnimal ModelArchitectureArteriesArteriovenous fistulaAtherosclerosisAutologousAutologous TransplantationAutomobile DrivingBiologicalBioreactorsBlood VesselsBlood flowBypassCaliberCardiovascular DiseasesCardiovascular systemCarotid ArteriesCellsClinicalCoronaryDataDepositionDevelopmentDevicesDiabetes MellitusDiameterElasticityElastomersElderlyExtracellular MatrixFiberGoalsHarvestHumanImmune responseImpairmentImplantIn SituInfiltrationInflammationInterleukin-10InterventionKidney FailureKneeKnowledgeLimb structureModelingMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusOperative Surgical ProceduresPathologyPatientsPerformanceProcessPropertyProteinsRattusResearchRodentRouteSheepSiteSourceSpeedSprague-Dawley RatsStromal CellsSystemic diseaseTechnologyTestingTissuesVascular GraftVein graftage effectagedartery occlusionbiodegradable scaffoldcell motilityclinical translationcomorbiditycontrolled releasecostcytokinedesigndiabeticeffectiveness evaluationelastomericendothelial stem cellgraft failuregraft functionimprovedinfection riskinsightnon-diabeticpatient populationpre-clinicalreconstructionscaffoldstem cell populationwound healing
项目摘要
Elastic, Degradable Vascular Grafts with Helical Microfibers
When an artery occludes, rerouting blood flow with a vascular graft can save lives or limbs.
Autologous grafts are the preferred conduit for replacing small-diameter vessels. However, not all
patients have suitable donor vessels, and the wound healing complications associated with the
harvest can be severe. Synthetic grafts can be used but the foreign material does not degrade or
integrate with the host, leading to graft failure and risk of infection. These grafts function best in
large caliber arterial reconstruction but perform poorly in smaller arteries such as in the coronary
and below the knee arteries. We will overcome this challenge by using a degradable graft made of
elastomeric microfibers arranged in helices mimicking extracellular matrix fibers in the artery. Our
preliminary data in rats show these grafts remodel into compliant, elastic vascular conduits
resembling the native arteries. The proposed research will address two key questions for clinical
translation: 1) will host cells fully populate the long grafts needed for human applications and 2)
will the same transformation occur in aged patients and those with systemic diseases such as
diabetes? Correspondingly, Specific Aim 1 will investigate host remodeling of 7-inch-long
interposition grafts in a sheep carotid artery. Aim 2 will assess graft remodeling in Zucker Diabetic
Sprague-Dawley rats, a new polygenetic model of Type 2 diabetes. Aim 3 will evaluate the
effectiveness of controlled release of cytokines in the graft to overcome the limitations caused by
aging. Upon completion of this project, we expect to have a graft design ready for clinical
translation. The knowledge gained will have impact beyond vascular substitutes in the
development of other cardiovascular devices.
具有螺旋微纤维的弹性可降解血管移植物
当动脉闭塞时,用血管移植物重新引导血流可以挽救生命或四肢。
自体移植物是替代小直径血管的首选管道。但并非所有
患者有合适的供体血管,与供体血管相关的伤口愈合并发症
收获可能很严重。可以使用合成移植物,但异物不会降解,
与宿主结合,导致移植失败和感染的风险。这些移植物的功能最好,
大口径动脉重建,但在较小的动脉,如冠状动脉,
以及膝盖以下的动脉我们将通过使用一种可降解的移植物来克服这一挑战,
以螺旋状排列的弹性微纤维模仿动脉中的细胞外基质纤维。我们
大鼠的初步数据显示,这些移植物重塑成顺应性,弹性血管导管
类似于天然动脉。这项研究将解决两个关键问题,
翻译:1)宿主细胞是否会完全填充人类应用所需的长移植物,以及2)
同样的转变是否会发生在老年患者和患有全身性疾病的患者身上,
糖尿病?相应地,具体目标1将研究7英寸长的
在羊颈动脉中插入移植物。目标2将评估Zucker糖尿病患者的移植物重塑
Sprague-Dawley大鼠,一种新的2型糖尿病多基因模型。目标3将评估
在移植物中控制释放细胞因子的有效性,以克服
衰老在这个项目完成后,我们希望有一个移植设计准备临床
翻译.所获得的知识将产生超出血管替代物的影响,
其他心血管设备的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edith Tzeng其他文献
Edith Tzeng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edith Tzeng', 18)}}的其他基金
Metformin BenefIts Lower Extremities with Intermittent Claudication (MOBILE_IC)
二甲双胍有益于间歇性跛行的下肢 (MOBILE_IC)
- 批准号:
10426266 - 财政年份:2022
- 资助金额:
$ 62.28万 - 项目类别:
Metformin BenefIts Lower Extremities with Intermittent Claudication (MOBILE_IC)
二甲双胍有益于间歇性跛行的下肢 (MOBILE_IC)
- 批准号:
10257312 - 财政年份:2022
- 资助金额:
$ 62.28万 - 项目类别:
Elastic, Degradable Vascular Grafts with Helical Microfibers
具有螺旋微纤维的弹性、可降解血管移植物
- 批准号:
10887286 - 财政年份:2021
- 资助金额:
$ 62.28万 - 项目类别:
Elastic, Degradable Vascular Grafts with Helical Microfibers
具有螺旋微纤维的弹性、可降解血管移植物
- 批准号:
10280660 - 财政年份:2021
- 资助金额:
$ 62.28万 - 项目类别:
Elastic, Degradable Vascular Grafts with Helical Microfibers
具有螺旋微纤维的弹性、可降解血管移植物
- 批准号:
10463745 - 财政年份:2021
- 资助金额:
$ 62.28万 - 项目类别:
Research Supplements to Promote Diversity in Vascular Graft Research
促进血管移植研究多样性的研究补充
- 批准号:
10619171 - 财政年份:2021
- 资助金额:
$ 62.28万 - 项目类别:
Xanthine oxidoreductase in impaired diabetic wound healing.
黄嘌呤氧化还原酶在糖尿病伤口愈合受损中的作用。
- 批准号:
10477928 - 财政年份:2016
- 资助金额:
$ 62.28万 - 项目类别:
Xanthine oxidoreductase in impaired diabetic wound healing.
黄嘌呤氧化还原酶在糖尿病伤口愈合受损中的作用。
- 批准号:
9138069 - 财政年份:2016
- 资助金额:
$ 62.28万 - 项目类别:
Xanthine oxidoreductase in impaired diabetic wound healing.
黄嘌呤氧化还原酶在糖尿病伤口愈合受损中的作用。
- 批准号:
10038744 - 财政年份:2016
- 资助金额:
$ 62.28万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 62.28万 - 项目类别:
Research Grant